Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.46 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | XIAP | P98170 | 1/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8357017 | 1.00 | EPHX1 (0.48) | EPHX1HRH1TRPA1SRRALPI | |
| SCHEMBL8356053 | 1.00 | EPHX1 (0.48) | EPHX1HRH1TRPA1SRRALPI | |
| SCHEMBL8643652 | 0.88 | HTR2A (0.50) | EPHX1HRH1TRPA1SRRALPI | |
| SCHEMBL5105980 | 0.86 | TRPA1 (0.52) | EPHX1TRPA1SRRALPIPKM | |
| SCHEMBL5678777 | 0.82 | EPHX1 (0.52) | EPHX1TRPA1SRRALPIPKM | |
| SCHEMBL7472546 | 0.82 | EPHX1 (0.52) | EPHX1TRPA1SRRALPIPKM | |
| SCHEMBL5097040 | 0.82 | TRPA1 (0.48) | EPHX1TRPA1SRRALPIPKM | |
| SCHEMBL194646 | 0.82 | EPHX1 (0.52) | EPHX1TRPA1SRRALPIPKM | |
| SCHEMBL1833635 | 0.81 | TRPA1 (0.55) | EPHX1TRPA1SRRALPIPKM | |
| SCHEMBL6680790 | 0.81 | HTR2A (0.54) | HRH1TAAR1CYP2A6MAOAHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7012099-B2 | Using substituted 4-amino-1- phenylbutan-2-ol compounds in form of their racemates, enantiomers, diastereoisomers or corresponding bases or corresponding salts of acids as regulators for the nociceptin/orphanin FQ ligands in drugs | GRUENENTHAL GMBH (DE) | 2006-03-14 | — | — | US | claimed |
| EP-1253917-B1 | USE OF SUBSTITUTED 4-AMINO-1-PHENYLBUTAN-2-OL COMPOUNDS AS MEDICAMENTS | GRUENENTHAL GMBH (DE) | 2005-02-16 | — | — | EP | claimed |
| US-20030008859-A1 | Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments | GRUENENTHAL GMBH (DE) | 2003-01-09 | — | — | US | claimed |
| EP-1253917-A2 | USE OF SUBSTITUTED 4-AMINO-1-PHENYLBUTAN-2-OL COMPOUNDS AS MEDICAMENTS | Grünenthal GmbH (DE) | 2002-11-06 | — | — | EP | claimed |
| WO-2001047506-A2 | USE OF SUBSTITUTED 4-AMINO-1-PHENYLBUTAN-2-OL COMPOUNDS AS MEDICAMENTS | Grünenthal GmbH (DE) | 2001-07-05 | — | — | WO | claimed |
| US-4522984-A | WITH E-CAPROLACTONE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1985-06-11 | — | — | US | claimed |
| CN-115677800-A | Pseudomonas aeruginosa O10 serotype O-antigen trisaccharide and synthetic method thereof | 山东大学 | 2023-02-03 | — | — | CN | disclosed |
| EP-3823628-A1 | <SMALLCAPS/>? ? ?S? ? ? ? ?CERTAIN (2)- <NS1:I>N</NS1:I>?-[(1 <NS2:I>S</NS2:I>?)-1-CYANO-2-PHENYLETHYL]-1,4- OXAZEPANE-2-CARBOXAMIDES FOR TREATING INFLAMMATORY BOWEL DISEASE | Insmed Incorporated (US) | 2021-05-26 | — | — | EP | disclosed |
| EP-3823627-A1 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING LUPUS NEPHRITIS | Insmed Incorporated (US) | 2021-05-26 | — | — | EP | disclosed |
| WO-2020018547-A1 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING LUPUS NEPHRITIS | INSMED INCORPORATED (US) | 2020-01-23 | — | — | WO | disclosed |
| WO-2020018551-A1 | CERTAIN (2S)- N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4- OXAZEPANE-2-CARBOXAMIDES FOR TREATING INFLAMMATORY BOWEL DISEASE | INSMED INCORPORATED (US) | 2020-01-23 | — | — | WO | disclosed |
| CN-110483492-A | Dipeptidyl peptidase i inhibitors | ASTRAZENECA AB | 2019-11-22 | — | — | CN | disclosed |
| CN-105980367-B | (2S) -N- [ (1S) -1-cyano-2-phenylethyl ] -1, 4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors | 阿斯利康(瑞典)有限公司 | 2019-08-23 | — | — | CN | disclosed |
| WO-2001047506-A2 | USE OF SUBSTITUTED 4-AMINO-1-PHENYLBUTAN-2-OL COMPOUNDS AS MEDICAMENTS | Grünenthal GmbH (DE) | 2001-07-05 | — | — | WO | disclosed |
| EP-0876381-A1 | IFOSFAMIDE, ANALOGUES THEREOF AND THEIR PREPARATION | Darwin Discovery Limited (GB) | 1998-11-11 | — | — | EP | disclosed |
| WO-1998010286-A1 | METHODS FOR PROCESSING CHEMICAL COMPOUNDS HAVING REACTIVE FUNCTIONAL GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 1998-03-12 | — | — | WO | disclosed |
| WO-1998005961-A1 | COMPOUNDS HAVING A PLURALITY OF NITROGENOUS SUBSTITUENTS | ISIS PHARMACEUTICALS, INC. (US) | 1998-02-12 | — | — | WO | disclosed |
| WO-1997022614-A1 | IFOSFAMIDE, ANALOGUES THEREOF AND THEIR PREPARATION | DARWIN DISCOVERY LIMITED (GB) | 1997-06-26 | — | — | WO | disclosed |
| US-4522984-A | WITH E-CAPROLACTONE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1985-06-11 | — | — | US | disclosed |
| US-4521570-A | Modified epoxy resin and composition | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1985-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008859-A1 | Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments | OPRL1, OPRM1, OPRK1 | EPHX1 1622/4885HRH1 224/4885TRPA1 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.